The role of glypicans in mammalian development.

Glypicans are a family of heparan sulfate proteoglycans that are bound to the cell surface by a glycosyl-phosphatidylinositol anchor. Six members of this family have been identified in mammals. In general, glypicans are highly expressed during development, and their expression pattern suggests that they are involved in morphogenesis. One member of this family, glypican-3, is mutated in the Simpson-Golabi-Behmel syndrome. This syndrome is characterized by overgrowth and various developmental abnormalities that indicate that glypican-3 inhibits proliferation and cell survival in the embryo. It has consequently been proposed that glypicans can regulate the activity of several growth factors that play a critical role in morphogenesis.

[1]  J. Filmus,et al.  Expression of OCI-5/glypican 3 during intestinal morphogenesis: regulation by cell shape in intestinal epithelial cells. , 1997, Experimental cell research.

[2]  J. Testa,et al.  OCI-5/GPC3, a Glypican Encoded by a Gene That Is Mutated in the Simpson-Golabi-Behmel Overgrowth Syndrome, Induces Apoptosis in a Cell Line–specific Manner , 1998, The Journal of cell biology.

[3]  Thierry Arnould,et al.  The Polycystic Kidney Disease 1 Gene Product Modulates Wnt Signaling* , 1999, The Journal of Biological Chemistry.

[4]  D. Rifkin,et al.  An endogenous glycosylphosphatidylinositol-specific phospholipase D releases basic fibroblast growth factor-heparan sulfate proteoglycan complexes from human bone marrow cultures. , 1994, Blood.

[5]  A. Lander,et al.  Expression of the heparan sulfate proteoglycan glypican‐1 in the developing rodent , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.

[6]  A. Lander,et al.  Expression of the cell surface proteoglycan glypican-5 is developmentally regulated in kidney, limb, and brain. , 1997, Developmental biology.

[7]  G. David,et al.  Developmental roles of the glypicans. , 2001, Seminars in cell & developmental biology.

[8]  P. Marynen,et al.  Glypican-6, a New Member of the Glypican Family of Cell Surface Heparan Sulfate Proteoglycans* , 1999, The Journal of Biological Chemistry.

[9]  Masato Kato,et al.  Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2 , 1998, Nature Medicine.

[10]  A. Lander,et al.  Mechanisms Underlying Preferential Assembly of Heparan Sulfate on Glypican-1* , 2001, The Journal of Biological Chemistry.

[11]  A. Behmel,et al.  A new X-linked dysplasia gigantism syndrome: Identical with the Simpson dysplasia syndrome? , 2004, Human Genetics.

[12]  D. Carey,et al.  Synthesis and processing of glypican during differentiation of skeletal muscle cells. , 1996, European journal of cell biology.

[13]  J. Chun,et al.  Glypican‐4 is an FGF2‐binding heparan sulfate proteoglycan expressed in neural precursor cells , 2000, Developmental dynamics : an official publication of the American Association of Anatomists.

[14]  J. Turnbull,et al.  Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains. , 1994, The Journal of biological chemistry.

[15]  A. Lander,et al.  Cerebroglycan, a developmentally regulated cell-surface heparan sulfate proteoglycan, is expressed on developing axons and growth cones. , 1997, Developmental biology.

[16]  S. Selleck,et al.  The cell-surface proteoglycan Dally regulates Wingless signalling in Drosophila , 1999, Nature.

[17]  J. Turnbull,et al.  Structural Modification of Fibroblast Growth Factor-binding Heparan Sulfate at a Determinative Stage of Neural Development* , 1998, The Journal of Biological Chemistry.

[18]  A. Lander,et al.  Cerebroglycan: an integral membrane heparan sulfate proteoglycan that is unique to the developing nervous system and expressed specifically during neuronal differentiation , 1994, The Journal of cell biology.

[19]  A. Amores,et al.  The zebrafish glypican knypek controls cell polarity during gastrulation movements of convergent extension. , 2001, Developmental cell.

[20]  D. Hoessli,et al.  Microdomains in lymphocyte signalling: beyond GPI-anchored proteins. , 2000, Immunology today.

[21]  R. Weksberg,et al.  Molecular genetics of Wiedemann-Beckwith syndrome. , 1998, American journal of medical genetics.

[22]  J. Bodurtha,et al.  Report of another family with Simpson-Golabi-Behmel syndrome and a review of the literature. , 1992, American journal of medical genetics.

[23]  R. Weksberg,et al.  GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome. , 2001, American journal of medical genetics.

[24]  R. G. Anderson,et al.  Potocytosis: sequestration and transport of small molecules by caveolae. , 1992, Science.

[25]  E. Wagner,et al.  Regulation of embryonic growth and lysosomal targeting by the imprintedIgf2/Mpr gene , 1994, Nature.

[26]  P. Antin,et al.  Expression of avian glypican is developmentally regulated , 1996, Developmental dynamics : an official publication of the American Association of Anatomists.

[27]  J. Church,et al.  Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine , 1988, Molecular and cellular biology.

[28]  A. McMahon,et al.  Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4 , 1994, Nature.

[29]  Ziying Liu,et al.  Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. , 1994, Genes & development.

[30]  J. Esko,et al.  Repetitive Ser-Gly Sequences Enhance Heparan Sulfate Assembly in Proteoglycans (*) , 1995, The Journal of Biological Chemistry.

[31]  E. Ikonen,et al.  Functional rafts in cell membranes , 1997, Nature.

[32]  P. Marynen,et al.  Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts , 1990, The Journal of cell biology.

[33]  D. Carey,et al.  Identification of a lipid-anchored heparan sulfate proteoglycan in Schwann cells , 1990, The Journal of cell biology.

[34]  T. Ludwig,et al.  Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. , 1997, Genes & development.

[35]  M. Golabi,et al.  A new X-linked mental retardation-overgrowth syndrome. , 1984, American journal of medical genetics.

[36]  D. Schlessinger,et al.  Simpson-Golabi-Behmel syndrome: genotype/phenotype analysis of 18 affected males from 7 unrelated families. , 1996, American journal of medical genetics.

[37]  H. Haubeck,et al.  Expression of glypican-4 in haematopoietic-progenitor and bone-marrow-stromal cells. , 1999, The Biochemical journal.

[38]  P. Marynen,et al.  Characterization of glypican-5 and chromosomal localization of human GPC5, a new member of the glypican gene family. , 1997, Genomics.

[39]  D. Schlessinger,et al.  Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome , 1996, Nature Genetics.

[40]  V. Nurcombe,et al.  Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan. , 1993, Science.

[41]  J. Filmus,et al.  OCI-5/Rat Glypican-3 Binds to Fibroblast Growth Factor-2 but Not to Insulin-like Growth Factor-2* , 1997, The Journal of Biological Chemistry.

[42]  P. Roughley,et al.  Glypican and Biglycan in the Nuclei of Neurons and Glioma Cells: Presence of Functional Nuclear Localization Signals and Dynamic Changes in Glypican During the Cell Cycle , 1997, The Journal of cell biology.

[43]  S. Selleck,et al.  dally, a Drosophila glypican, controls cellular responses to the TGF-beta-related morphogen, Dpp. , 1997, Development.

[44]  A. Schmidtchen,et al.  Degradation and Reprocessing of Heparan Sulphate in Recycling Glypican (Heparan Sulphate Proteoglycan) , 1998 .

[45]  S. Selleck,et al.  Glypicans: proteoglycans with a surprise. , 2001, The Journal of clinical investigation.

[46]  W. Skarnes,et al.  glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development. , 2000, Developmental biology.

[47]  N. Perrimon,et al.  Dally cooperates with Drosophila Frizzled 2 to transduce Wingless signalling , 1999, Nature.

[48]  S. Selleck,et al.  The division abnormally delayed (dally) gene: a putative integral membrane proteoglycan required for cell division patterning during postembryonic development of the nervous system in Drosophila. , 1995, Development.

[49]  J. Filmus,et al.  Identification of a new membrane-bound heparan sulphate proteoglycan. , 1995, The Biochemical journal.

[50]  Deborah A. Brown,et al.  Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface , 1992, Cell.

[51]  K. Watanabe,et al.  K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney , 1995, The Journal of cell biology.

[52]  H. van den Berghe,et al.  Heparan sulfate expression in polarized epithelial cells: the apical sorting of glypican (GPI-anchored proteoglycan) is inversely related to its heparan sulfate content , 1996, The Journal of cell biology.

[53]  C. McKerlie,et al.  Glypican-3–Deficient Mice Exhibit Developmental Overgrowth and Some of the Abnormalities Typical of Simpson-Golabi-Behmel Syndrome , 1999, The Journal of cell biology.

[54]  T. Ludwig,et al.  Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. , 1996, Developmental biology.

[55]  D. Carey,et al.  Developmental and cell-type-specific expression of cell surface heparan sulfate proteoglycans in the rat heart. , 1997, Experimental cell research.

[56]  M. Götte,et al.  Functions of cell surface heparan sulfate proteoglycans. , 1999, Annual review of biochemistry.

[57]  N. Rosenblum,et al.  Glypican-3 modulates BMP- and FGF-mediated effects during renal branching morphogenesis. , 2001, Developmental biology.

[58]  A. Mackenzie,et al.  A small interstitial deletion in the GPC3 gene causes Simpson-Golabi-Behmel syndrome in a Dutch-Canadian family , 1999, Journal of medical genetics.

[59]  A. Kahn,et al.  Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the β-catenin gene , 2001, Oncogene.

[60]  D. Schlessinger,et al.  Gpc3 expression correlates with the phenotype of the Simpson‐Golabi‐Behmel syndrome , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.